Melanie Gloria

CIK: 0001973838

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)15 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMVT

Immunovant, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

IMVT
Immunovant, Inc.
Oct 7, 2026
Sale(S)
Direct
2.2K shares at avg. $32.06$72K
IMVT
Immunovant, Inc.
Aug 20, 2026
Sale(S)
Direct
3.1K shares at avg. $44.16$135K
IMVT
Immunovant, Inc.
Jul 8, 2026
Sale(S)
Direct
106 shares at avg. $39.99$4K
IMVT
Immunovant, Inc.
Jul 8, 2026
Sale(S)
Direct
1.9K shares at avg. $39.53$76K
IMVT
Immunovant, Inc.
Jun 26, 2026
Sale(S)
Direct
14.7K shares at avg. $38.18$563K
IMVT
Immunovant, Inc.
Jun 26, 2026
Sale(S)
Direct
3K shares at avg. $38.95$116K
IMVT
Immunovant, Inc.
May 20, 2026
Sale(S)
Direct
1.7K shares at avg. $32.95$56K
IMVT
Immunovant, Inc.
May 20, 2026
Sale(S)
Direct
249 shares at avg. $30.41$8K
IMVT
Immunovant, Inc.
May 20, 2026
Sale(S)
Direct
1.2K shares at avg. $32.15$38K
IMVT
Immunovant, Inc.
Apr 8, 2026
Sale(S)
Direct
8.7K shares at avg. $24.83$217K
IMVT
Immunovant, Inc.
Apr 7, 2026
Award(A)
Direct
83.7K shares-
IMVT
Immunovant, Inc.
Feb 25, 2026
Sale(S)
Direct
859 shares at avg. $28.16$24K
IMVT
Immunovant, Inc.
Feb 25, 2026
Sale(S)
Direct
1.4K shares at avg. $26.98$39K
IMVT
Immunovant, Inc.
Feb 25, 2026
Sale(S)
Direct
942 shares at avg. $28.90$27K
IMVT
Immunovant, Inc.
Nov 20, 2025
Sale(S)
Direct
2.4K shares at avg. $23.97$57K
IMVT
Immunovant, Inc.
Nov 20, 2025
Sale(S)
Direct
10.3K shares at avg. $23.54$241K
IMVT
Immunovant, Inc.
Apr 1, 2025
Award(A)
Direct
76.2K shares-
IMVT
Immunovant, Inc.
Nov 18, 2024
Award(A)
Direct
110K shares-

		Type	Shares	Price		Ownership
Oct 7, 2026	IMVT Immunovant, Inc.	Sale(S)	2,241	$32.06	$71,846	Direct
Aug 20, 2026	IMVT Immunovant, Inc.	Sale(S)	3,056	$44.16	$134,953	Direct
Jul 8, 2026	IMVT Immunovant, Inc.	Sale(S)	106	$39.99	$4,239	Direct
Jul 8, 2026	IMVT Immunovant, Inc.	Sale(S)	1,930	$39.53	$76,293	Direct
Jun 26, 2026	IMVT Immunovant, Inc.	Sale(S)	14,748	$38.18	$563,079	Direct
Jun 26, 2026	IMVT Immunovant, Inc.	Sale(S)	2,966	$38.95	$115,526	Direct
May 20, 2026	IMVT Immunovant, Inc.	Sale(S)	1,698	$32.95	$55,949	Direct
May 20, 2026	IMVT Immunovant, Inc.	Sale(S)	249	$30.41	$7,572	Direct
May 20, 2026	IMVT Immunovant, Inc.	Sale(S)	1,168	$32.15	$37,551	Direct
Apr 8, 2026	IMVT Immunovant, Inc.	Sale(S)	8,722	$24.83	$216,567	Direct
Apr 7, 2026	IMVT Immunovant, Inc.	Award(A)	83,671	-	$0	Direct
Feb 25, 2026	IMVT Immunovant, Inc.	Sale(S)	859	$28.16	$24,189	Direct
Feb 25, 2026	IMVT Immunovant, Inc.	Sale(S)	1,437	$26.98	$38,770	Direct
Feb 25, 2026	IMVT Immunovant, Inc.	Sale(S)	942	$28.90	$27,224	Direct
Nov 20, 2025	IMVT Immunovant, Inc.	Sale(S)	2,375	$23.97	$56,929	Direct
Nov 20, 2025	IMVT Immunovant, Inc.	Sale(S)	10,251	$23.54	$241,309	Direct
Apr 1, 2025	IMVT Immunovant, Inc.	Award(A)	76,181	-	-	Direct
Nov 18, 2024	IMVT Immunovant, Inc.	Award(A)	109,956	-	$0	Direct

1-18 of 18 transactions

About Gloria Melanie

Gloria Melanie (SEC CIK 0001973838) files insider reports with the SEC as Chief Operating Officer of Immunovant, Inc. (IMVT).

Signal8 holds 12 ownership filings by Gloria Melanie (1 Form 3, 11 Form 4), filed between Nov 20, 2024 and Oct 9, 2026. Those filings report 18 transactions, from Nov 18, 2024 to Oct 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gloria Melanie's filings is in DURHAM, NC.

Recent filings by Gloria Melanie

Oct 7, 2026: Open-market sale of IMVT shares (Form 4, code S).
Aug 20, 2026: Open-market sale of IMVT shares (Form 4, code S).
Jul 8, 2026: Open-market sales of IMVT shares (2 lines, Form 4, code S).
Jun 26, 2026: Open-market sales of IMVT shares (2 lines, Form 4, code S).
May 20, 2026: Open-market sales of IMVT shares (3 lines, Form 4, code S).

Other insiders filing for Immunovant, Inc. (IMVT)

Girao Tiago, Chief Financial Officer
Stout Jay S, Chief Technology Officer
Van Tuyl Christopher, Chief Legal Officer
Venker Eric, Chief Executive Officer
Pande Atul, Director
Fromkin Andrew J., Director

How to read Form 4 transaction codes